Lead Assets

KWB01-A

KWB01-A shows inhibitory activities against BRD4 (BD1+BD2) and BRD2 (BD1+BD21).

We expect that KWB01-A as a novel drug candidate having activity against age-related

diseases such as diabetic retinopathy, atherosclerosis, rheumatoid arthritis,

and inflammatory diseases.

KWB01-A Screen Shot 2020-01-20 at 5.42.4

DMPK

KWB01-A DMPK1 Screen Shot 2020-01-20 at
 

KWB04-B

KWB04-B shows inhibitory activities against BRD4(BD1+BD2), BRD2 (BD1+BD2).

KWB04-B Screen Shot 2020-01-20 at 5.40.5

DMPK

KWB04-B DMPK2 Screen Shot 2020-01-20 at
 

KWB04-C

KWB04-C has BD2-specific inhibitory activity against BRD4(BD2) and BRD2(BD2).

KWB04-C Screen Shot 2020-01-20 at 5.45.2

DMPK

KWB04-C  DMPK3 Screen Shot 2020-01-20 at